| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 7, 2016New iPro(TM)2 myLog App Collects Data from Continuous Glucose Monitors (CGM) and Fitbit Activity Trackers, Provides Meaningful Insights on How Exercise Impacts Glucose Levels
DUBLIN and SAN FRANCISCO - Dec. 7, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, and Fitbit (NYSE: FIT), the leader in the connected health and fitness market,...
-
Dec 6, 2016Medtronic is First and Only Company to Receive Approval for a ChEVAR Indication, Providing an Off-the-Shelf Option for Patients with Complex Aneurysms
DUBLIN – Dec. 6, 2016 – Medtronic plc (NYSE:MDT) today announced that it has received CE (Conformité Européenne) Mark for the Endurant™ II/IIs stent graft system to treat abdominal aortic...
-
Dec 1, 2016Medtronic Introduces First-and-Only Recapturable TAVI System Available in Japan
DUBLIN - Dec. 1, 2016 - Medtronic plc (NYSE: MDT) today announced it has received reimbursement approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the recapturable,...
-
Nov 29, 2016New Implant Option Gives Physicians Surgical Alternative for Patients with Advanced Heart Failure
DUBLIN - Nov. 29, 2016 - Medtronic plc (NYSE: MDT) today announced that its HVAD® System left ventricular assist device (LVAD) received CE (Conformité Européenne) Mark for a less-invasive...
-
Nov 29, 2016New Agreement Focuses on Improved System Efficiency at University Hospitals Cleveland Medical Center
DUBLIN and CLEVELAND - Nov. 29, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the signing of its first Integrated Health Solutions agreement in the...
-
Nov 22, 2016Revenue of $7.3 Billion Grew 4% as Reported; 3% at Constant Currency
DUBLIN - November 22, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2017, which ended October 28, 2016. The company reported second...
-
Nov 17, 2016Data from ANCHOR Registry Demonstrate Applicability in Patients with Hostile Aortic Neck Anatomy
DUBLIN and NEW YORK - Nov. 17, 2016 - Medtronic plc (NYSE: MDT) today announced data demonstrating that the company's Heli-FX(TM) EndoAnchor(TM) system enhances outcomes and durability in patients...
-
Nov 16, 2016FDA Allows Use of the Most Studied Stent Retriever with IV-tPA
DUBLIN - Nov. 16, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for the Solitaire(TM) stent retriever device....
-
Nov 16, 2016Report Highlights Company's Global Financial, Social, and Environmental Impact
DUBLIN - Nov. 16, 2016 - Medtronic plc (NYSE:MDT) announces the release of its 2016 Integrated Performance Report. The report highlights - for the first time - the combined financial, social, and...
-
Nov 15, 2016New Data from the Global ENGAGE Registry Builds on Durability of Endurant, with Strong Outcomes Out to Four Years in Patients with Standard and Hostile Neck Anatomies
DUBLIN - Nov. 15, 2016 - Medtronic plc (NYSE:MDT) today announced data supporting the strength and durability of the Endurant(TM) II/IIs1 stent graft system to treat abdominal aortic aneurysm...
-
Nov 14, 2016First CRT-D in U.S. to Help Improve Therapy Delivery in Heart Failure Patients Using Effective Pacing
DUBLIN - Nov. 14, 2016 - Medtronic plc (NYSE:MDT) has received U.S. Food and Drug Administration (FDA) approval for the Claria MRI(TM) Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D)...
-
Nov 14, 2016
DUBLIN - Nov. 14, 2016 - Medtronic plc (NYSE: MDT) today announced notable presentations of clinical studies on how endovascular treatments are furthering the treatment of core and complex aortic...
-
Nov 11, 2016
DUBLIN - Nov. 11, 2016 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its second quarter of fiscal year 2017 on Tuesday, November 22, 2016. A news release...
-
Nov 10, 2016Orthopedic Solutions Offers Comprehensive Services for Joint Replacement Episodes of Care, Including the Launch of a Total Knee Arthroplasty System
DUBLIN and DALLAS - Nov. 10, 2016 - Medtronic plc (NYSE: MDT) today announced the launch of Medtronic Orthopedic Solutions, a comprehensive offering for total joint replacement episodes of care...
-
Nov 1, 2016New Data from Evolut R U.S. IDE study presented at TCT Reveals Positive Clinical Performance for the Recapturable TAVR Device, Including the First-of-its-Kind 34 mm Valve
DUBLIN and WASHINGTON, D.C. - Nov. 1, 2016 - Medtronic plc (NYSE: MDT) unveiled new clinical data showing that patients treated with the self-expanding CoreValve(TM) Evolut(TM) R System continued...
-
Nov 1, 2016FDA Approves IDE Study Initiation Following Positive Results from First-of-its-Kind Early Feasibility Study Presented at TCT
DUBLIN and WASHINGTON, D.C. - Nov. 1, 2016 - Medtronic plc (NYSE: MDT) today announced new clinical data for the Harmony(TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study,...
-
Oct 31, 2016Results from FORWARD and STS/ACC TVT Registry Demonstrate High Survival and Low Rate of All Stroke for Next-Generation TAVR Device in Everyday Clinical Practice
DUBLIN and WASHINGTON, DC - Oct. 31, 2016 - Medtronic plc (NYSE: MDT) today presented new positive data from two large registries aimed at evaluating 30-day clinical performance outcomes for the...
-
Oct 31, 2016Featured 'First Report' RevElution Trial at TCT Highlights the Potential Benefits of First-of-its-Kind Polymer-Free Technology with Controlled and Sustained Drug Delivery for Rapid Vessel Healing
DUBLIN and WASHINGTON, D.C. - Oct. 31, 2016 - Medtronic plc (NYSE: MDT) unveiled today the first clinical outcomes of its novel Drug-Filled Stent (DFS) from the RevElution Trial at the...
-
Oct 30, 2016BIO-RESORT Demonstrates Excellent Clinical Outcomes for Medtronic Resolute(TM) Integrity(TM) DES, a Gold Standard for Percutaneous Coronary Intervention
DUBLIN and WASHINGTON, DC - Oct. 30, 2016 - Investigators today unveiled clinical data from the independent BIO-RESORT study, representing the first all-comers analysis to compare the safety and...
-
Oct 27, 2016Medtronic joins the Global Framework for Stroke Care on World Stroke Day
DUBLIN and HYDERABAD, India - Oct. 27, 2016 - In recognition of World Stroke Day, Medtronic plc (NYSE:MDT) and the World Stroke Organization (WSO) joined together for the third year to raise...
-
Oct 26, 2016Launch of 34 mm Self-Expanding Evolut R Device Expands TAVR Treatment to Patients Who Could Not be Treated Previously
DUBLIN - Oct. 26, 2016 - Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the CoreValve(TM) Evolut(TM) R 34 mm valve-the largest...
-
Oct 24, 2016MiniMed Connect Mobile Accessory Provides Easier and Better Access to Pump and CGM Data, Helping Optimize Therapy for Improved Glycemic Patterns
DUBLIN - October 24, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. commercial availability of the Android(TM) operating system version of the...
-
Oct 24, 2016New Technology Expands Treatment Options for Patients with Peripheral Artery Disease Both Above and Below the Knee
DUBLIN - Oct. 24, 2016 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the HawkOne(TM) Directional Atherectomy System in a new size for...
-
Oct 21, 2016
DUBLIN - Oct. 21, 2016 - Medtronic plc (NYSE:MDT) today announced the company will webcast investor and analyst briefings at two upcoming medical conferences. Medtronic will host a webcast to...
-
Oct 14, 2016
DUBLIN - Oct. 14, 2016 - Medtronic plc (NYSE: MDT) today announced that it has notified customers of a voluntary recall of certain lots of its Pipeline(TM) embolization device, Alligator(TM)...